PUBLISHER: The Business Research Company | PRODUCT CODE: 1945379
PUBLISHER: The Business Research Company | PRODUCT CODE: 1945379
Injectable cement is a bone cement used in orthopedic procedures to stabilize fractures, support implants, or fill bone defects. It is injected under imaging guidance for precise placement, enabling minimally invasive treatment and immediate stabilization to improve patient recovery.
The main categories of injectable cement include high-viscosity cement, low-viscosity cement, and medium-viscosity cement. High-viscosity cement has a thicker consistency, resulting in reduced fluidity while offering enhanced stability after hardening, making it suitable for applications requiring strong and long-lasting fixation, such as high-load fractures or complex joint replacement procedures. The applications include periprosthetic fractures, pelvic fractures, and others, and the end users include hospitals, clinics, and others.
Tariffs are impacting the injectable cement market by increasing the cost of imported raw materials such as polymers, bioactive compounds, and specialized packaging. High and medium viscosity cement segments are particularly affected, with regions like Asia-Pacific and Europe experiencing pricing pressure due to import duties. These cost increases have influenced procurement decisions for hospitals and clinics. However, tariffs have also encouraged local manufacturing, supply chain diversification, and innovation in cost-effective cement formulations, supporting long-term market sustainability.
The injectable cement market research report is one of a series of new reports from The Business Research Company that provides injectable cement market statistics, including injectable cement industry global market size, regional shares, competitors with a injectable cement market share, detailed injectable cement market segments, market trends and opportunities, and any further data you may need to thrive in the injectable cement industry. This injectable cement market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The injectable cement market size has grown strongly in recent years. It will grow from $1.55 billion in 2025 to $1.66 billion in 2026 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to increasing incidence of bone fractures, reliance on traditional orthopedic fixation methods, growing elderly population, expansion of hospital-based orthopedic care, adoption of PMMA-based bone cements.
The injectable cement market size is expected to see strong growth in the next few years. It will grow to $2.13 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to technological advancements in injectable cement formulations, rising demand for minimally invasive surgeries, increasing orthopedic trauma cases, growth in outpatient and clinic-based procedures, higher focus on biocompatible and bioactive materials. Major trends in the forecast period include rising adoption of minimally invasive orthopedic procedures, growing use of injectable cement in fracture stabilization, increasing preference for image-guided cement injection, advancements in bioactive and composite injectable cements, improved focus on faster recovery and patient outcomes.
The increasing number of sports-related injuries is increasingly supporting the expansion of the injectable cement market going forward. Sports-related injuries include physical damage such as fractures, sprains, strains, and joint injuries sustained during athletic activities. The rise in sports-related injuries is associated with greater participation in sports, more intensive training programs, and increased physical demands placed on athletes. Injectable cement is used to stabilize fractures, support bone healing, and improve surgical outcomes by offering a minimally invasive and effective solution for bone reinforcement. For example, in July 2025, according to the Australian Institute of Health and Welfare, an Australia-based government agency, cycling accounted for approximately 12% of sports-related hospitalizations in 2023-24, followed by Australian rules football and soccer. As a result, the growing number of sports-related injuries is contributing to the expansion of the injectable cement market.
Leading companies operating in the injectable cement market are focusing on technological advancements such as antibiotic-loaded bone cement to enhance infection control, improve patient outcomes, and support more targeted orthopedic treatments. Antibiotic-loaded bone cement is a specialized bone cement formulation containing antibiotics to help prevent or manage infections at surgical sites, particularly in orthopedic procedures. For example, in April 2024, Heraeus Medical GmbH, a Germany-based medical technology manufacturer, launched COPAL G+C, its latest antibiotic-loaded bone cement and the company's first product certified under the Medical Device Regulation (MDR). COPAL G+C combines gentamicin and clindamycin, enabling targeted infection management in arthroplasty by addressing up to 90% of pathogens commonly linked to prosthetic joint infections.
In September 2023, Globus Medical Inc., a US-based provider of musculoskeletal solutions, including orthopedic cement, merged with NuVasive Inc. for an undisclosed amount. This merger is intended to reinforce its position in spinal surgery technologies, enhance its ability to deliver innovative minimally invasive solutions, and drive market growth. NuVasive Inc. is a US-based medical device company offering spinal treatment solutions, including injectable bone cement.
Major companies operating in the injectable cement market are Johnson & Johnson, Stryker Corporation, Zimmer Biomet Holdings Inc, Smith & Nephew, Arthrex Inc, Enovis Corporation, Globus Medical Inc, Wright Medical Group N.V, Medacta International, Orthofix Medical Inc, Alphatec Spine Inc, Exactech Inc, Spine Wave Inc, Tecres SpA, Heraeus Medical GmbH, TEKNIMED, Graftys SA, Solco Biomedical, Terumo Corporation, Bonesupport AB, Peregrine Biologics, aap Implantate AG, Biometrix Ltd, OSARTIS GmbH, IZI Medical
North America was the largest region in the injectable cement market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the injectable cement market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the injectable cement market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The injectable cement market consists of sales of antibiotic-loaded bone cements, calcium phosphate cements, customizable injectable cement, and bioactive glass cement. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Injectable Cement Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses injectable cement market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for injectable cement ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The injectable cement market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.